Clinical and Radiological Improvement Following a Switch to Upadacitinib in Giant Cell Arteritis with Recurrent Ischemic Strokes During High-Dose Glucocorticoid and Tocilizumab Treatment: A Case Report

Giant cell arteritis (GCA) is a systemic rheumatic disease that affects the large vessels. Although ischemic stroke is an uncommon complication of GCA, intracranial vasculitis may lead to recurrent strokes. An 81-year-old man presented with progressive gait disturbance. Physical examination revealed bilateral temporal artery tenderness with markedly diminished pulsation. His serum C-reactive protein level was elevated. Temporal artery ultrasonography demonstrated bilateral halo signs. Brain magnetic resonance imaging revealed multiple acute strokes. Vessel wall imaging demonstrated circumferential wall thickening with contrast enhancement of the bilateral intracranial internal carotid and vertebral arteries. He fulfilled the 2022 ACR/EULAR classification criteria for GCA. Treatment with intravenous methylprednisolone followed by high-dose glucocorticoid (GC) and weekly subcutaneous (SC) tocilizumab (TCZ) was initiated. However, recurrent ischemic strokes occurred early after treatment initiation, accompanied by progression of intracranial arterial stenosis. Therefore, TCZ was subsequently switched to upadacitinib (UPA) 15 mg/day. Following the switch to UPA, the serum C-reactive protein level normalized, no further ischemic strokes occurred, and follow-up contrast-enhanced MRI demonstrated resolution of vascular wall enhancement. This case describes clinical and radiological improvement observed following the switch to UPA in rapidly progressive GCA with intracranial involvement.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2026-11-16
DOI
https://doi.org/10.1093/mrcr/rxag101
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical and Radiological Improvement Following a Switch to Upadacitinib in Giant Cell Arteritis with Recurrent Ischemic Strokes During High-Dose Glucocorticoid and Tocilizumab Treatment: A Case Report

Haruka Yonezawa, Shin‐ichiro Ohmura, Soma Fukami, Kazuki Tomiyama et al.
Modern Rheumatology Case Reports
Vasculitis and related conditions
article

Clinical and Radiological Improvement Following a Switch to Upadacitinib in Giant Cell Arteritis with Recurrent Ischemic Strokes During High-Dose Glucocorticoid and Tocilizumab Treatment: A Case Report

Haruka Yonezawa, Shin‐ichiro Ohmura, Soma Fukami, Kazuki Tomiyama, Tadashi Aoki
article en

Abstract

Giant cell arteritis (GCA) is a systemic rheumatic disease that affects the large vessels. Although ischemic stroke is an uncommon complication of GCA, intracranial vasculitis may lead to recurrent strokes. An 81-year-old man presented with progressive gait disturbance. Physical examination revealed bilateral temporal artery tenderness with markedly diminished pulsation. His serum C-reactive protein level was elevated. Temporal artery ultrasonography demonstrated bilateral halo signs. Brain magnetic resonance imaging revealed multiple acute strokes. Vessel wall imaging demonstrated circumferential wall thickening with contrast enhancement of the bilateral intracranial internal carotid and vertebral arteries. He fulfilled the 2022 ACR/EULAR classification criteria for GCA. Treatment with intravenous methylprednisolone followed by high-dose glucocorticoid (GC) and weekly subcutaneous (SC) tocilizumab (TCZ) was initiated. However, recurrent ischemic strokes occurred early after treatment initiation, accompanied by progression of intracranial arterial stenosis. Therefore, TCZ was subsequently switched to upadacitinib (UPA) 15 mg/day. Following the switch to UPA, the serum C-reactive protein level normalized, no further ischemic strokes occurred, and follow-up contrast-enhanced MRI demonstrated resolution of vascular wall enhancement. This case describes clinical and radiological improvement observed following the switch to UPA in rapidly progressive GCA with intracranial involvement.

Modern Rheumatology Case Reports
Seirei Hamamatsu General Hospital (JP)
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon